Pfizer COVID-19 Vaccine Sales Plunge 25% Amid New Guidance
URGENT UPDATE: Pfizer’s U.S. sales of its COVID-19 vaccine, Comirnaty, have plummeted by 25%, dropping to $870 million in the third quarter of 2023. This dramatic decline follows new federal…